-
-
Oude Lashof and colleagues examined the incidence and outcomes of patients with ocular involvement in a randomized, clinical trial comparing treatment of non-neutropenic patients with candidemia with either voriconazole or amphotericin B followed by fluconazole.
-
A 58-year-old Liberian-born woman was in excellent general health, living and working in a large academic medical center in Rhode Island for more than 20 years, when she developed nonspecific gastrointestinal symptoms and underwent endoscopy, which revealed Strongyloides stercoralis larvae on a duodenal biopsy in March 2010.
-
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
A total of 130 singleton stillbirths from a single institution in Australia, from January 2005 through December 2006, of > 20 weeks gestation with no cause of death and with available formalin-fixed, paraffin-embedded tissues were examined by multiplex PCR for 19 infectious agents, and by immunohistochemistry for human cytomegalovirus (CMV).
-
The authors conducted a series of experiments in which HIV-1 transfected 1G5 T cells were exposed to either a series of known long terminal repeat (TLR) ligands (FimH/TLR-4, flagellin/TLR-5, and poly I:C/TLR-3) or STI pathogens (HSV-1, HSV-2, and N. gonorrhoeae).
-
As mandatory flu immunization policies continue to gain momentum in health care settings, egg allergy one of the classic exemptions to the vaccine is being redefined by public health officials.
-
Infection preventionists at Vanderbilt Medical Center in Nashville have developed a comprehensive glucometer cleaning protocol that other IPs may want to emulate as regulators respond to outbreaks of hepatitis B virus in diabetics and other patients.
-
A clinic in Madison, WI has contacted 2,345 patients to advise them they may have been exposed to bloodborne pathogens after finding an employee was inappropriately using insulin pens and finger stick devices during patient training.
-
The following FAQs summarize inquiries from healthcare personnel received by the Centers for Disease Control & Prevention regarding best practices for performance of assisted blood glucose monitoring and insulin administration.
